Alternatives to Geneyx Genomex

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI-powered spatial biology platform for precision medicine and drug development.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Developing novel diagnostics to predict patient response to immunotherapy.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

Transforming healthcare by turning scientific fiction into scientific facts.

Develops a computational model of the human body for drug discovery and development.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Bioinformatics platform for rapid discovery and validation of precision mental health treatments.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

Next-generation molecular diagnostics for immediate and accurate pathogen detection anywhere.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

MedHub-AI develops an AI-based decision support system for interventional cardiologists to enable precision cardiac care.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

Global life sciences company providing diagnostic and biopharma laboratory services.

Leveraging the adaptive immune system to diagnose and treat disease.

AI-driven platform for faster and more efficient diagnosis of women's health issues.

Develops AI-powered decision support tools for personalized medical data interpretation and prediction.

Biotechnology company personalizing medical cannabis treatment using metabolic biomarker analysis.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

Platform for managing high-risk populations prone to severe illnesses, enabling early diagnosis and cost reduction.

A medical platform connecting patients and physicians with genetic expertise.

AI-powered blood analysis for precise substance tracing and classification in healthcare and research.

Microbiome technology platform for developing novel therapeutics.

AI-powered platform to predict and prevent adverse drug reactions, reducing hospitalizations.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Medical device company developing advanced sensor technology for oncology treatment.

AI-powered platform enhancing surgical precision and patient outcomes through data-driven recommendations.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Advanced diagnostics for preventative health and personalized cancer treatment using AI and genomics.

AI-powered platform for personalized cell therapy development and manufacturing.

Biomedical platform with intelligent search for medical citations and clinical trial recruitment.

AI-powered blood test for early cancer detection and subtyping.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Data-driven software solutions for precision medicine and pharmaceutical development.

AI-powered breast cancer detection and risk assessment solutions.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

High-resolution T-cell receptor repertoire analysis for immunological insights and therapeutic development.

BioCorteX is a tech bio company developing precision medicine solutions using AI-powered in-silico simulations to understand drug-bacteria interactions and personalize treatments.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

Remote-controlled micro-robots for precise treatment of central nervous system disorders.

Comprehensive whole-genome monitoring for cancer recurrence and progression.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.